uniQure (QURE) Interest Coverage Ratio Growth (3y) (2019 - 2026)
uniQure (QURE) Interest Coverage Ratio Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 28.11% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | 40.09% |
| 10 | uniQure | 2.43 Bn | 2.43 Bn | 3.34 Mn | 45.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.92% |
| Dec 31, 2025 | -80.05% |
| Sep 30, 2025 | 42.99% |
| Jun 30, 2025 | 48.68% |
| Mar 31, 2025 | 34.44% |
| Dec 31, 2024 | -16.52% |
| Sep 30, 2024 | 53.04% |
| Jun 30, 2024 | -26.31% |
| Mar 31, 2024 | 51.02% |
| Dec 31, 2023 | -32.77% |
| Sep 30, 2023 | 52.49% |
| Jun 30, 2023 | 23.57% |
| Mar 31, 2023 | 18.67% |
| Dec 31, 2022 | -59.32% |
| Sep 30, 2022 | -2.92% |
| Jun 30, 2022 | 12.72% |
| Mar 31, 2022 | -3.37% |
| Dec 31, 2021 | 27.15% |
| Sep 30, 2021 | 20.44% |
| Jun 30, 2021 | 90.70% |